Over a whirlwind three weeks, Sarepta Therapeutics has faced tough safety questions around its commercial gene therapy ...

Sun Pharmaceutical's shares declined following a reported 20% YoY drop in Q1FY26 net profit, despite a 10% increase in ...

In Q1 FY26, external sales of API were at Rs 540.4 crore, up by 9.3%. The company's API portfolio supports formulation ...

IISR Surya is a high-yielding turmeric variety developed by ICAR-IISR, Kozhikode. With light-colored rhizomes ideal for ...